Oncolytics Biotech Ownership 2024 | Who Owns Oncolytics Biotech Now?


OverviewFinancialsChartTranscripts

Institutional Ownership

1.74%

Insider Ownership

3.82%

Retail Ownership

94.44%

Institutional Holders

41.00

Oncolytics Biotech Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC0.26%0.02%198,400-3,052-1.51%196,416Jun 30, 2024
SEEDS INVESTOR LLC0.25%0.10%189,941189,941100.00%188,042Jun 30, 2024
MORGAN STANLEY0.18%-138,521-209,792-60.23%137,136Jun 30, 2024
GOLDMAN SACHS GROUP INC0.11%-83,598--82,762Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.08%0.00%63,1143500.56%62,000Jun 30, 2024
ROYAL BANK OF CANADA0.08%-62,2671,2342.02%62,000Jun 30, 2024
CIBC WORLD MARKET INC.0.08%0.00%57,835-315-0.54%57,000Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.06%-41,942--41,522Jun 30, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC0.05%0.00%40,000--39,600Jun 30, 2024
BANK OF MONTREAL /CAN/0.05%-37,4251050.28%38,851Jun 30, 2024
VIRTU FINANCIAL LLC0.04%0.00%27,442-24,447-47.11%27,000Jun 30, 2024
BRAVE ASSET MANAGEMENT INC0.03%0.01%25,000--24,667Jun 30, 2024
NATIONAL BANK OF CANADA /FI/0.03%-21,69710,00085.49%21,435Jun 30, 2024
AUSDAL FINANCIAL PARTNERS, INC.0.03%0.00%21,000-5,000-19.23%20,790Jun 30, 2024
LPL FINANCIAL LLC0.03%-20,5092,50013.88%20,304Jun 30, 2024
HEADINVEST, LLC0.02%0.00%17,4349005.44%17,260Jun 30, 2024
C2P CAPITAL ADVISORY GROUP, LLC D.B.A. PROSPERITY CAPITAL ADVISORS0.02%0.00%15,000--14,850Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC0.02%0.00%13,29410,000303.58%13,110Jun 30, 2024
BANQUE CANTONALE VAUDOISE0.02%0.00%11,900--12,000Jun 30, 2024
KINGSVIEW WEALTH MANAGEMENT, LLC0.01%0.00%11,000--10,890Jun 30, 2024

Oncolytics Biotech's largest institutional shareholder is INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, holding 0.26% of the company's total share outstanding, currently valued at $196.42K. The top 10 institutional shareholders own together 1.21% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SEEDS INVESTOR LLC0.25%0.10%189,941189,941100.00%188,042Jun 30, 2024
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC0.26%0.02%198,400-3,052-1.51%196,416Jun 30, 2024
BRAVE ASSET MANAGEMENT INC0.03%0.01%25,000--24,667Jun 30, 2024
HEADINVEST, LLC0.02%0.00%17,4349005.44%17,260Jun 30, 2024
AUSDAL FINANCIAL PARTNERS, INC.0.03%0.00%21,000-5,000-19.23%20,790Jun 30, 2024
VIRTU FINANCIAL LLC0.04%0.00%27,442-24,447-47.11%27,000Jun 30, 2024
C2P CAPITAL ADVISORY GROUP, LLC D.B.A. PROSPERITY CAPITAL ADVISORS0.02%0.00%15,000--14,850Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT0.01%0.00%5,0005,000100.00%4,950Jun 30, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC0.05%0.00%40,000--39,600Jun 30, 2024
CEDAR MOUNTAIN ADVISORS, LLC0.01%0.00%5,651--5,594Jun 30, 2024
PROFESSIONAL ADVISORY SERVICES INC0.01%0.00%10,000--10,000Jun 30, 2024
PFG INVESTMENTS, LLC0.01%0.00%10,500--10,395Jun 30, 2024
BANQUE CANTONALE VAUDOISE0.02%0.00%11,900--12,000Jun 30, 2024
KINGSVIEW WEALTH MANAGEMENT, LLC0.01%0.00%11,000--10,890Jun 30, 2024
CIBC WORLD MARKET INC.0.08%0.00%57,835-315-0.54%57,000Jun 30, 2024
IFP ADVISORS, INC0.00%0.00%2,500--2,475Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.08%0.00%63,1143500.56%62,000Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC0.02%0.00%13,29410,000303.58%13,110Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.00%0.00%3,2393,239100.00%3,193Jun 30, 2024
PACIFICA PARTNERS INC.0.00%-100100100.00%101Jun 30, 2024

The largest Oncolytics Biotech shareholder by % of total assets is SEEDS INVESTOR LLC. The company owns 189.94K shares of Oncolytics Biotech (ONCY), representing 0.10% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SEEDS INVESTOR LLC0.25%0.10%189,941189,941100.00%188,042Jun 30, 2024
NATIONAL BANK OF CANADA /FI/0.03%-21,69710,00085.49%21,435Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC0.02%0.00%13,29410,000303.58%13,110Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT0.01%0.00%5,0005,000100.00%4,950Jun 30, 2024
UBS GROUP AG0.01%-5,6034,439381.36%5,547Jun 30, 2024
TOWER RESEARCH CAPITAL LLC (TRC)0.00%0.00%3,2393,239100.00%3,193Jun 30, 2024
LPL FINANCIAL LLC0.03%-20,5092,50013.88%20,304Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-2,0002,000100.00%2,060Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC0.00%-1,9001,900100.00%1,881Jun 30, 2024
ROYAL BANK OF CANADA0.08%-62,2671,2342.02%62,000Jun 30, 2024
HEADINVEST, LLC0.02%0.00%17,4349005.44%17,260Jun 30, 2024
TD WATERHOUSE CANADA INC.0.00%-662662100.00%1,032Jun 30, 2024
TORONTO DOMINION BANK0.00%-474474100.00%469Jun 30, 2024
COMMONWEALTH EQUITY SERVICES, LLC0.08%0.00%63,1143500.56%62,000Jun 30, 2024
BANK OF MONTREAL /CAN/0.05%-37,4251050.28%38,851Jun 30, 2024
PACIFICA PARTNERS INC.0.00%-100100100.00%101Jun 30, 2024
0.00%-5656100.00%55Jun 30, 2024
1832 ASSET MANAGEMENT L.P.--5--5Jun 30, 2024
WELLS FARGO & COMPANY/MN0.01%-4,401--4,356Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.06%-41,942--41,522Jun 30, 2024

As of Jun 30 2024, Oncolytics Biotech's largest institutional buyer is SEEDS INVESTOR LLC. The company purchased 189.94K stocks of ONCY, valued at $188.04K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MORGAN STANLEY0.18%-138,521-209,792-60.23%137,136Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----40,887-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC0.04%0.00%27,442-24,447-47.11%27,000Jun 30, 2024
TWO SIGMA SECURITIES, LLC----11,816-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----11,500-100.00%-Jun 30, 2024
ATOM INVESTORS LP----10,257-100.00%-Jun 30, 2024
AUSDAL FINANCIAL PARTNERS, INC.0.03%0.00%21,000-5,000-19.23%20,790Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.01%-8,497-4,842-36.30%8,411Jun 30, 2024
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC0.26%0.02%198,400-3,052-1.51%196,416Jun 30, 2024
CWM, LLC0.00%-1,325-1,000-43.01%1,000Jun 30, 2024
CIBC WORLD MARKET INC.0.08%0.00%57,835-315-0.54%57,000Jun 30, 2024
BRAVE ASSET MANAGEMENT INC0.03%0.01%25,000--24,667Jun 30, 2024
C2P CAPITAL ADVISORY GROUP, LLC D.B.A. PROSPERITY CAPITAL ADVISORS0.02%0.00%15,000--14,850Jun 30, 2024
LONG FOCUS CAPITAL MANAGEMENT, LLC0.05%0.00%40,000--39,600Jun 30, 2024
CEDAR MOUNTAIN ADVISORS, LLC0.01%0.00%5,651--5,594Jun 30, 2024
PROFESSIONAL ADVISORY SERVICES INC0.01%0.00%10,000--10,000Jun 30, 2024
PFG INVESTMENTS, LLC0.01%0.00%10,500--10,395Jun 30, 2024
BANQUE CANTONALE VAUDOISE0.02%0.00%11,900--12,000Jun 30, 2024
KINGSVIEW WEALTH MANAGEMENT, LLC0.01%0.00%11,000--10,890Jun 30, 2024
IFP ADVISORS, INC0.00%0.00%2,500--2,475Jun 30, 2024

As of Jun 30 2024, Oncolytics Biotech's biggest institutional seller is MORGAN STANLEY. The company sold -0.21M shares of ONCY, valued at $137.14K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SEEDS INVESTOR LLC0.25%0.10%189,941189,941100.00%188,042Jun 30, 2024
ACTIVEST WEALTH MANAGEMENT0.01%0.00%5,0005,000100.00%4,950Jun 30, 2024
ALLWORTH FINANCIAL LP0.00%-2,0002,000100.00%2,060Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC0.00%-1,9001,900100.00%1,881Jun 30, 2024
PACIFICA PARTNERS INC.0.00%-100100100.00%101Jun 30, 2024
0.00%-5656100.00%55Jun 30, 2024

Oncolytics Biotech's largest new institutional shareholder by number of shares is SEEDS INVESTOR LLC, purchased 189.94K shares, valued at $188.04K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC----40,887-100.00%-Jun 30, 2024
TWO SIGMA SECURITIES, LLC----11,816-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO----11,500-100.00%-Jun 30, 2024
ATOM INVESTORS LP----10,257-100.00%-Jun 30, 2024

Oncolytics Biotech's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -40.89K shares, valued at -, as of undefined.

Oncolytics Biotech Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
DFA INVESTMENT TRUST CO0.00%33,485--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%41,942--Feb 29, 2024

Oncolytics Biotech's largest mutual fund holder by % of total assets is "DFA INVESTMENT TRUST CO", owning 33.48K shares, compromising 0.00% of its total assets.

Oncolytics Biotech Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 244117.14%
31 Mar, 2435-18.60%
31 Dec, 234330.30%
30 Sep, 233310.00%
30 Jun, 2330-6.25%
31 Mar, 2332-8.57%
31 Dec, 223512.90%
30 Sep, 2231-16.22%
30 Jun, 22372.78%
31 Mar, 2236-2.70%
31 Dec, 213715.63%
30 Sep, 2132-15.79%
30 Jun, 21382.70%
31 Mar, 213723.33%
31 Dec, 2030-3.23%
30 Sep, 2031-
30 Jun, 20313.33%
31 Mar, 203025.00%
31 Dec, 1924100.00%
30 Sep, 1912-20.00%
30 Jun, 1915-11.76%
31 Mar, 191721.43%
31 Dec, 1814-17.65%
30 Sep, 1817-5.56%
30 Jun, 1818-

As of 30 Jun 24, 41 institutions are holding Oncolytics Biotech's shares, representing an increase of 17.14% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 241,309,286-7.29%
31 Mar, 241,412,246-72.26%
31 Dec, 235,090,222-18.12%
30 Sep, 236,216,786663.94%
30 Jun, 23813,781-28.53%
31 Mar, 231,138,57726.03%
31 Dec, 22903,44926.13%
30 Sep, 22716,262-21.53%
30 Jun, 22912,74329.71%
31 Mar, 22703,685-41.61%
31 Dec, 211,205,09115.02%
30 Sep, 211,047,702-0.52%
30 Jun, 211,053,1380.04%
31 Mar, 211,052,670-1.72%
31 Dec, 201,071,08835.06%
30 Sep, 20793,054-2.47%
30 Jun, 20813,13738.21%
31 Mar, 20588,33851.69%
31 Dec, 19387,8550.87%
30 Sep, 19384,506-32.24%
30 Jun, 19567,457204.42%
31 Mar, 19186,40325.00%
31 Dec, 18149,117-16.40%
30 Sep, 18178,371-69.16%
30 Jun, 18578,446-

Oncolytics Biotech (ONCY) has 1.31M shares outstanding as of 30 Jun 24, down -7.29% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 241.74%47.43%
31 Mar, 241.92%3.60%
31 Dec, 237.29%7.84%
30 Sep, 239.64%565.98%
30 Jun, 231.31%39.13%
31 Mar, 231.83%36.41%
31 Dec, 222.24%148.50%
30 Sep, 221.23%49.02%
30 Jun, 221.58%102.31%
31 Mar, 221.24%25.87%
31 Dec, 212.19%60.34%
30 Sep, 211.91%50.72%
30 Jun, 211.94%43.16%
31 Mar, 212.12%32.16%
31 Dec, 202.57%71.05%
30 Sep, 201.90%45.09%
30 Jun, 202.05%76.30%
31 Mar, 201.64%53.44%
31 Dec, 191.75%60.75%
30 Sep, 191.70%21.48%
30 Jun, 192.81%274.76%
31 Mar, 191.01%116.71%
31 Dec, 180.93%80.06%
30 Sep, 181.08%7.65%
30 Jun, 183.75%-

As of 30 Jun 24, Oncolytics Biotech is held by 1.74% institutional shareholders, representing a 47.43% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 241828.57%
31 Mar, 2414-33.33%
31 Dec, 232131.25%
30 Sep, 231645.45%
30 Jun, 2311-31.25%
31 Mar, 2316-5.88%
31 Dec, 221754.55%
30 Sep, 2211-
30 Jun, 2211-26.67%
31 Mar, 2215-25.00%
31 Dec, 2120100.00%
30 Sep, 2110-33.33%
30 Jun, 2115-37.50%
31 Mar, 212460.00%
31 Dec, 201525.00%
30 Sep, 2012-25.00%
30 Jun, 2016-
31 Mar, 2016-11.11%
31 Dec, 1918157.14%
30 Sep, 197-
30 Jun, 197-
31 Mar, 19740.00%
31 Dec, 185-50.00%
30 Sep, 1810-44.44%
30 Jun, 1818-

18 institutional shareholders have increased their position in ONCY stock as of 30 Jun 24 compared to 14 in the previous quarter (a 28.57% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 248-
31 Mar, 248-20.00%
31 Dec, 2310100.00%
30 Sep, 235-28.57%
30 Jun, 23775.00%
31 Mar, 234-20.00%
31 Dec, 225150.00%
30 Sep, 222-77.78%
30 Jun, 229-10.00%
31 Mar, 2210150.00%
31 Dec, 214-50.00%
30 Sep, 218-
30 Jun, 218100.00%
31 Mar, 214-
31 Dec, 204-42.86%
30 Sep, 20740.00%
30 Jun, 205-
31 Mar, 20525.00%
31 Dec, 194300.00%
30 Sep, 191-75.00%
30 Jun, 194-
31 Mar, 194-
31 Dec, 18433.33%
30 Sep, 183-
30 Jun, 18--

8 institutional shareholders have reduced their position in ONCY stock as of 30 Jun 24 compared to 8 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 244117.14%1,309,286-7.29%1.74%47.43%1828.57%8-
31 Mar, 2435-18.60%1,412,246-72.26%1.92%3.60%14-33.33%8-20.00%
31 Dec, 234330.30%5,090,222-18.12%7.29%7.84%2131.25%10100.00%
30 Sep, 233310.00%6,216,786663.94%9.64%565.98%1645.45%5-28.57%
30 Jun, 2330-6.25%813,781-28.53%1.31%39.13%11-31.25%775.00%
31 Mar, 2332-8.57%1,138,57726.03%1.83%36.41%16-5.88%4-20.00%
31 Dec, 223512.90%903,44926.13%2.24%148.50%1754.55%5150.00%
30 Sep, 2231-16.22%716,262-21.53%1.23%49.02%11-2-77.78%
30 Jun, 22372.78%912,74329.71%1.58%102.31%11-26.67%9-10.00%
31 Mar, 2236-2.70%703,685-41.61%1.24%25.87%15-25.00%10150.00%
31 Dec, 213715.63%1,205,09115.02%2.19%60.34%20100.00%4-50.00%
30 Sep, 2132-15.79%1,047,702-0.52%1.91%50.72%10-33.33%8-
30 Jun, 21382.70%1,053,1380.04%1.94%43.16%15-37.50%8100.00%
31 Mar, 213723.33%1,052,670-1.72%2.12%32.16%2460.00%4-
31 Dec, 2030-3.23%1,071,08835.06%2.57%71.05%1525.00%4-42.86%
30 Sep, 2031-793,054-2.47%1.90%45.09%12-25.00%740.00%
30 Jun, 20313.33%813,13738.21%2.05%76.30%16-5-
31 Mar, 203025.00%588,33851.69%1.64%53.44%16-11.11%525.00%
31 Dec, 1924100.00%387,8550.87%1.75%60.75%18157.14%4300.00%
30 Sep, 1912-20.00%384,506-32.24%1.70%21.48%7-1-75.00%
30 Jun, 1915-11.76%567,457204.42%2.81%274.76%7-4-
31 Mar, 191721.43%186,40325.00%1.01%116.71%740.00%4-
31 Dec, 1814-17.65%149,117-16.40%0.93%80.06%5-50.00%433.33%
30 Sep, 1817-5.56%178,371-69.16%1.08%7.65%10-44.44%3-
30 Jun, 1818-578,446-3.75%-18---

Oncolytics Biotech Peer Ownership


TickerCompany
XFORX4 Pharmaceuticals, Inc.
IKTInhibikase Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
SCPHscPharmaceuticals Inc.
HOOKHOOKIPA Pharma Inc.
CVACCureVac N.V.
MCRBSeres Therapeutics, Inc.
TERNTerns Pharmaceuticals, Inc.
VIRVir Biotechnology, Inc.
KRYSKrystal Biotech, Inc.
DMACDiaMedica Therapeutics Inc.
MISTMilestone Pharmaceuticals Inc.
LIFEaTyr Pharma, Inc.

ONCY Ownership FAQ


Oncolytics Biotech is owned by institutional shareholders (1.74%), insiders (3.82%), and public (94.44%). The largest institutional shareholder of Oncolytics Biotech is INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC (0.26% of total shares) and the top mutual fund owner is DFA INVESTMENT TRUST CO (0.00% of total shares).

Oncolytics Biotech's major institutional shareholders are INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, SEEDS INVESTOR LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, and COMMONWEALTH EQUITY SERVICES, LLC. The top five shareholders own together 0.90% of the company's share outstanding.

As of Jun 2024, there are 41 institutional shareholders of Oncolytics Biotech.

INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC owns 198.4K shares of Oncolytics Biotech, representing 0.26% of the company's total shares outstanding, valued at $196.42K (as of Jun 2024).

As of Jun 2024, SEEDS INVESTOR LLC holds 189.94K shares of Oncolytics Biotech (ONCY), compromising 0.25% of the company, valued at $188.04K.

MORGAN STANLEY is the third largest holder of Oncolytics Biotech. The company owns 138.52K of the company's shares outstanding (worth $137.14K).